查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566944

临床决策支援平台市场：按组件、交付格式、应用程式和最终用户分类：2024-2033 年全球机会分析和产业预测

Clinical Decision Support Platform Market By Component , By Delivery Mode By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3个工作天内

价格
简介目录

临床决策支援平台市场

2023年临床决策支援平台市场价值为12亿美元，预计2024年至2033年复合年增长率为7.3%，到2033年达到24亿美元。

临床决策支援平台是旨在透过完善决策流程来增强医疗保健服务的系统。该平台将患者资料和健康记录与现有资料库和评估进行比较，并提供量身定制的建议。该平台旨在透过准确的诊断、优化的​​治疗计划、减少错误和遵守适当的实践来提高医疗保健服务的品质。

各地区医疗保健和病人安全支出的增加正在推动临床决策支援平台市场的成长。临床决策支援平台也面临很高的需求，因为它们有助于优化资源利用，并透过减少不必要的再入院病例来帮助降低成本。在数位时代，利用人工智慧和深度学习特性的临床决策支援平台备受关注。人工智慧使得在短时间内准确评估和解释大量资料成为可能。此外，深度学习透过预测分析、模式分析和影像识别补充了人工智慧的特性。

然而，安装和维护平台以及建立必要的资源和基础设施是一个昂贵的过程，这成长抑制因素。此外，这些平檯面临资料外洩和网路攻击的高风险，阻碍了市场开拓。例如，美国医疗保健公司 Change Healthcare 在 2024 年 2 月成为勒索软体攻击的目标，​​由于未授权存取，数百万美国人的健康资料受到损害。

按部门审查

临床决策支援平台市场分为组件、交付格式、应用程式、最终用户和区域。按组件划分，市场分为软体和服务。根据提供形式的不同，分为本地部署和云端基础。依用途分为药物过敏警示、临床指引、药物交互作用、临床提醒等。依最终用户划分，可分为医院、诊所、门诊医疗中心和学术/研究机构。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲地区。

主要发现

从组成部分来看，软体产业将在 2023 年占据市场主导地位。

从交付模式来看，本地部署细分市场在 2023 年占据了较高的市场。

从应用来看，药物交互作用领域在2023年占据了较高的市场占有率。

按最终用户划分，医院细分市场在 2023 年将占据较高市场份额。

按地区划分，北美地区 2023 年收益最高。

该报告可以定制。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 公司简介的扩充列表
  • 历史市场资料
  • 赎回场景

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章临床决策支援平台市场：按组成部分

  • 市场概况
  • 软体
  • 服务

第五章 临床决策支援平台市场：依规定格式

  • 市场概况
  • 本地
  • 云端基础

第六章临床决策支援平台市场：依应用分类

  • 市场概况
  • 药物过敏警告
  • 临床指引
  • 药物间相互作用
  • 临床提醒
  • 其他的

第七章 临床决策支援平台市场：依最终使用者分类

  • 市场概况
  • 医院
  • 诊所
  • 门诊治疗中心
  • 学术研究所

第八章临床决策支援平台市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国临床决策支援平台市场
    • 加拿大临床决策支援平台市场
    • 墨西哥临床决策支援平台市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国临床决策支援平台市场
    • 德国临床决策支援平台市场
    • 义大利临床决策支援平台市场
    • 西班牙临床决策支援平台市场
    • 英国临床决策支援平台市场
    • 其他欧洲国家临床决策支援平台市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国临床决策支援平台市场
    • 日本临床决策支援平台市场
    • 印度临床决策支援平台市场
    • 韩国临床决策支援平台市场
    • 澳洲临床决策支援平台市场
    • 其他亚太临床决策支援平台市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西临床决策支援平台市场
    • 南非临床决策支援平台市场
    • 沙乌地阿拉伯临床决策支援平台市场
    • 其他拉丁美洲/中东/非洲临床决策支援平台市场

第9章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第十章 公司简介

  • Cerner Corporation
  • EPIC Systems Corporation
  • IBM
  • Change Healthcare Corporation
  • Medical Information Technology Inc
  • Koninklijke Philips NV
  • Siemens Healthcare
  • Allscripts Healthcare Solutions Inc.
  • Wolters Kluwer NV
  • McKesson Corporation.
简介目录
Product Code: A323980

Clinical Decision Support Platform Market

The clinical decision support platform market was valued at $1.2 billion in 2023 and is projected to reach $2.4 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.

Clinical decision support platform is a system designed to enhance the delivery of healthcare by refining the decision-making process. The platform compares patient data & health records with the existing database & assessments and provides tailored recommendations. The aim of the platform is to elevate the quality of healthcare delivery through precise diagnoses, optimized treatment plans, reduced errors, and strict adherence to appropriate practices.

Increase in expenditure of healthcare and patient safety across different regions is driving the growth of the clinical decision support platform market. In addition, the clinical decision support platform is witnessing a high demand as it aids in cost savings by facilitating the optimal usage of resources and reducing the cases of unnecessary hospital readmissions. In the digital era, clinical decision support platforms powered by the properties of AI and deep learning are gaining prominence. AI enables the precise assessment and interpretation of loads of data in a short span of time. Moreover, deep learning complements the attributes of AI through predictive analysis, pattern analysis, and image recognition.

However, the installation and maintenance of the platform, along with the assembly of necessary resources & infrastructure is an expensive process that restraints the growth of the clinical decision support platform market. Furthermore, these platforms remain at a high risk of data breach and cyberattacks, which hampers the market development. For instance, Change Healthcare-an American healthcare company-was targeted to a ransomware attack on February 2024, risking the health data of millions of Americans due to unauthorized access.

Segment Review

The clinical decision support platform market is segmented into component, delivery mode, application, end user, and region. On the basis of component, the market is bifurcated into software and services. As per delivery mode, it is divided into on-premises and cloud based. Depending on application, it is classified into drug allergy alerts, clinical guidelines, drug-drug interactions, clinical reminders, and others. By end user, it is categorized into hospitals, clinics, ambulatory care centers, and academic & research institutes. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of component, the software segment dominated the market in 2023.

As per delivery mode, the on-premises segment acquired a high stake in the market in 2023.

Depending on application, the drug-drug interactions segment accounted for a high market share in 2023.

By end user, the hospitals segment was the highest shareholder of the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players of the global clinical decision support platform market include Cerner Corporation, EPIC Systems Corporation, IBM, Change Healthcare Corporation, Medical Information Technology Inc, Koninklijke Philips NV, Siemens Healthcare, Allscripts Healthcare Solutions Inc., Wolters Kluwer NV, and McKesson Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Component

  • Software
  • Services

By Delivery Mode

  • On-Premises
  • Cloud Based

By Application

  • Drug Allergy Alerts
  • Clinical Guidelines
  • Drug-Drug Interactions
  • Clinical Reminders
  • Others

By End User

  • Hospitals
  • Clinics
  • Ambulatory Care Centers
  • Academic and Research Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Cerner Corporation
    • EPIC Systems Corporation
    • IBM
    • Change Healthcare Corporation
    • Medical Information Technology Inc
    • Koninklijke Philips NV
    • Siemens Healthcare
    • Allscripts Healthcare Solutions Inc.
    • Wolters Kluwer NV
    • McKesson Corporation.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Component
  • 4.2. Software
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Services
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Delivery Mode
  • 5.2. On-Premises
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Cloud Based
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Drug Allergy Alerts
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Clinical Guidelines
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Drug-Drug Interactions
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Clinical Reminders
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Others
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country

CHAPTER 7: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By End User
  • 7.2. Hospitals
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Clinics
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Ambulatory Care Centers
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Academic And Research Institutes
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country

CHAPTER 8: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY REGION

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Component
    • 8.2.3. Market Size and Forecast, By Delivery Mode
    • 8.2.4. Market Size and Forecast, By Application
    • 8.2.5. Market Size and Forecast, By End User
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. U.S. Clinical Decision Support Platform Market
      • 8.2.7.1. Market Size and Forecast, By Component
      • 8.2.7.2. Market Size and Forecast, By Delivery Mode
      • 8.2.7.3. Market Size and Forecast, By Application
      • 8.2.7.4. Market Size and Forecast, By End User
    • 8.2.8. Canada Clinical Decision Support Platform Market
      • 8.2.8.1. Market Size and Forecast, By Component
      • 8.2.8.2. Market Size and Forecast, By Delivery Mode
      • 8.2.8.3. Market Size and Forecast, By Application
      • 8.2.8.4. Market Size and Forecast, By End User
    • 8.2.9. Mexico Clinical Decision Support Platform Market
      • 8.2.9.1. Market Size and Forecast, By Component
      • 8.2.9.2. Market Size and Forecast, By Delivery Mode
      • 8.2.9.3. Market Size and Forecast, By Application
      • 8.2.9.4. Market Size and Forecast, By End User
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Component
    • 8.3.3. Market Size and Forecast, By Delivery Mode
    • 8.3.4. Market Size and Forecast, By Application
    • 8.3.5. Market Size and Forecast, By End User
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. France Clinical Decision Support Platform Market
      • 8.3.7.1. Market Size and Forecast, By Component
      • 8.3.7.2. Market Size and Forecast, By Delivery Mode
      • 8.3.7.3. Market Size and Forecast, By Application
      • 8.3.7.4. Market Size and Forecast, By End User
    • 8.3.8. Germany Clinical Decision Support Platform Market
      • 8.3.8.1. Market Size and Forecast, By Component
      • 8.3.8.2. Market Size and Forecast, By Delivery Mode
      • 8.3.8.3. Market Size and Forecast, By Application
      • 8.3.8.4. Market Size and Forecast, By End User
    • 8.3.9. Italy Clinical Decision Support Platform Market
      • 8.3.9.1. Market Size and Forecast, By Component
      • 8.3.9.2. Market Size and Forecast, By Delivery Mode
      • 8.3.9.3. Market Size and Forecast, By Application
      • 8.3.9.4. Market Size and Forecast, By End User
    • 8.3.10. Spain Clinical Decision Support Platform Market
      • 8.3.10.1. Market Size and Forecast, By Component
      • 8.3.10.2. Market Size and Forecast, By Delivery Mode
      • 8.3.10.3. Market Size and Forecast, By Application
      • 8.3.10.4. Market Size and Forecast, By End User
    • 8.3.11. UK Clinical Decision Support Platform Market
      • 8.3.11.1. Market Size and Forecast, By Component
      • 8.3.11.2. Market Size and Forecast, By Delivery Mode
      • 8.3.11.3. Market Size and Forecast, By Application
      • 8.3.11.4. Market Size and Forecast, By End User
    • 8.3.12. Rest of Europe Clinical Decision Support Platform Market
      • 8.3.12.1. Market Size and Forecast, By Component
      • 8.3.12.2. Market Size and Forecast, By Delivery Mode
      • 8.3.12.3. Market Size and Forecast, By Application
      • 8.3.12.4. Market Size and Forecast, By End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Component
    • 8.4.3. Market Size and Forecast, By Delivery Mode
    • 8.4.4. Market Size and Forecast, By Application
    • 8.4.5. Market Size and Forecast, By End User
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. China Clinical Decision Support Platform Market
      • 8.4.7.1. Market Size and Forecast, By Component
      • 8.4.7.2. Market Size and Forecast, By Delivery Mode
      • 8.4.7.3. Market Size and Forecast, By Application
      • 8.4.7.4. Market Size and Forecast, By End User
    • 8.4.8. Japan Clinical Decision Support Platform Market
      • 8.4.8.1. Market Size and Forecast, By Component
      • 8.4.8.2. Market Size and Forecast, By Delivery Mode
      • 8.4.8.3. Market Size and Forecast, By Application
      • 8.4.8.4. Market Size and Forecast, By End User
    • 8.4.9. India Clinical Decision Support Platform Market
      • 8.4.9.1. Market Size and Forecast, By Component
      • 8.4.9.2. Market Size and Forecast, By Delivery Mode
      • 8.4.9.3. Market Size and Forecast, By Application
      • 8.4.9.4. Market Size and Forecast, By End User
    • 8.4.10. South Korea Clinical Decision Support Platform Market
      • 8.4.10.1. Market Size and Forecast, By Component
      • 8.4.10.2. Market Size and Forecast, By Delivery Mode
      • 8.4.10.3. Market Size and Forecast, By Application
      • 8.4.10.4. Market Size and Forecast, By End User
    • 8.4.11. Australia Clinical Decision Support Platform Market
      • 8.4.11.1. Market Size and Forecast, By Component
      • 8.4.11.2. Market Size and Forecast, By Delivery Mode
      • 8.4.11.3. Market Size and Forecast, By Application
      • 8.4.11.4. Market Size and Forecast, By End User
    • 8.4.12. Rest of Asia-Pacific Clinical Decision Support Platform Market
      • 8.4.12.1. Market Size and Forecast, By Component
      • 8.4.12.2. Market Size and Forecast, By Delivery Mode
      • 8.4.12.3. Market Size and Forecast, By Application
      • 8.4.12.4. Market Size and Forecast, By End User
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Component
    • 8.5.3. Market Size and Forecast, By Delivery Mode
    • 8.5.4. Market Size and Forecast, By Application
    • 8.5.5. Market Size and Forecast, By End User
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Clinical Decision Support Platform Market
      • 8.5.7.1. Market Size and Forecast, By Component
      • 8.5.7.2. Market Size and Forecast, By Delivery Mode
      • 8.5.7.3. Market Size and Forecast, By Application
      • 8.5.7.4. Market Size and Forecast, By End User
    • 8.5.8. South Africa Clinical Decision Support Platform Market
      • 8.5.8.1. Market Size and Forecast, By Component
      • 8.5.8.2. Market Size and Forecast, By Delivery Mode
      • 8.5.8.3. Market Size and Forecast, By Application
      • 8.5.8.4. Market Size and Forecast, By End User
    • 8.5.9. Saudi Arabia Clinical Decision Support Platform Market
      • 8.5.9.1. Market Size and Forecast, By Component
      • 8.5.9.2. Market Size and Forecast, By Delivery Mode
      • 8.5.9.3. Market Size and Forecast, By Application
      • 8.5.9.4. Market Size and Forecast, By End User
    • 8.5.10. Rest of LAMEA Clinical Decision Support Platform Market
      • 8.5.10.1. Market Size and Forecast, By Component
      • 8.5.10.2. Market Size and Forecast, By Delivery Mode
      • 8.5.10.3. Market Size and Forecast, By Application
      • 8.5.10.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top Winning Strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. Cerner Corporation
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Company Snapshot
    • 10.1.4. Operating Business Segments
    • 10.1.5. Product Portfolio
    • 10.1.6. Business Performance
    • 10.1.7. Key Strategic Moves and Developments
  • 10.2. EPIC Systems Corporation
    • 10.2.1. Company Overview
    • 10.2.2. Key Executives
    • 10.2.3. Company Snapshot
    • 10.2.4. Operating Business Segments
    • 10.2.5. Product Portfolio
    • 10.2.6. Business Performance
    • 10.2.7. Key Strategic Moves and Developments
  • 10.3. IBM
    • 10.3.1. Company Overview
    • 10.3.2. Key Executives
    • 10.3.3. Company Snapshot
    • 10.3.4. Operating Business Segments
    • 10.3.5. Product Portfolio
    • 10.3.6. Business Performance
    • 10.3.7. Key Strategic Moves and Developments
  • 10.4. Change Healthcare Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Key Executives
    • 10.4.3. Company Snapshot
    • 10.4.4. Operating Business Segments
    • 10.4.5. Product Portfolio
    • 10.4.6. Business Performance
    • 10.4.7. Key Strategic Moves and Developments
  • 10.5. Medical Information Technology Inc
    • 10.5.1. Company Overview
    • 10.5.2. Key Executives
    • 10.5.3. Company Snapshot
    • 10.5.4. Operating Business Segments
    • 10.5.5. Product Portfolio
    • 10.5.6. Business Performance
    • 10.5.7. Key Strategic Moves and Developments
  • 10.6. Koninklijke Philips NV
    • 10.6.1. Company Overview
    • 10.6.2. Key Executives
    • 10.6.3. Company Snapshot
    • 10.6.4. Operating Business Segments
    • 10.6.5. Product Portfolio
    • 10.6.6. Business Performance
    • 10.6.7. Key Strategic Moves and Developments
  • 10.7. Siemens Healthcare
    • 10.7.1. Company Overview
    • 10.7.2. Key Executives
    • 10.7.3. Company Snapshot
    • 10.7.4. Operating Business Segments
    • 10.7.5. Product Portfolio
    • 10.7.6. Business Performance
    • 10.7.7. Key Strategic Moves and Developments
  • 10.8. Allscripts Healthcare Solutions Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Key Executives
    • 10.8.3. Company Snapshot
    • 10.8.4. Operating Business Segments
    • 10.8.5. Product Portfolio
    • 10.8.6. Business Performance
    • 10.8.7. Key Strategic Moves and Developments
  • 10.9. Wolters Kluwer NV
    • 10.9.1. Company Overview
    • 10.9.2. Key Executives
    • 10.9.3. Company Snapshot
    • 10.9.4. Operating Business Segments
    • 10.9.5. Product Portfolio
    • 10.9.6. Business Performance
    • 10.9.7. Key Strategic Moves and Developments
  • 10.10. McKesson Corporation.
    • 10.10.1. Company Overview
    • 10.10.2. Key Executives
    • 10.10.3. Company Snapshot
    • 10.10.4. Operating Business Segments
    • 10.10.5. Product Portfolio
    • 10.10.6. Business Performance
    • 10.10.7. Key Strategic Moves and Developments